4//SEC Filing
Thorp Clay 4
Accession 0000899243-22-001658
CIK 0001827087other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 9:20 PM ET
Size
12.2 KB
Accession
0000899243-22-001658
Insider Transaction Report
Form 4
Thorp Clay
Director
Transactions
- Conversion
Series B Preferred Stock
2022-01-11−926,506→ 0 total(indirect: By Hatteras Venture Partners VI, L.P.)→ Common Stock (334,092 underlying) - Conversion
Common Stock
2022-01-11+1,254,335→ 1,254,335 total(indirect: By Hatteras Venture Partners VI, L.P.) - Conversion
Series A Preferred Stock
2022-01-11−2,552,021→ 0 total(indirect: By Hatteras Venture Partners VI, L.P.)→ Common Stock (920,243 underlying) - Purchase
Common Stock
2022-01-11$14.00/sh+265,000$3,710,000→ 1,519,335 total(indirect: By Hatteras Venture Partners VI, L.P.)
Footnotes (3)
- [F1]Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") on a one-for-2.7732 basis upon the closing of the Issuer's initial public offering on January 1, 2022 and had no expiration date.
- [F2]The shares are held directly by Hatteras Venture Partners VI, L.P. ("Hatteras VI"). Hatteras Venture Advisors VI, LLC ("HVA VI") is the general partner of Hatteras VI. The Reporting Person is a managing member of HVA VI and disclaims beneficial ownership of the shares held by Hatteras VI except to the extent of his pecuniary interest therein, if any.
- [F3]On January 11, 2022, Hatteras VI purchased 265,000 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.
Documents
Issuer
Vigil Neuroscience, Inc.
CIK 0001827087
Entity typeother
Related Parties
1- filerCIK 0001592380
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 9:20 PM ET
- Size
- 12.2 KB